ATE328879T1 - Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv - Google Patents

Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv

Info

Publication number: ATE328879T1
Authority: AT; Austria
Prior art keywords: hiv; treatment; receptor antagonists; piperidine derivatives; ccr5 receptor
Prior art date: 2001-08-29

Application number

AT02766142T

Other languages

English (en)

Inventor

Anandan Palani

Michael W Miller

Jack D Scott

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-29

Filing date

2002-08-28

Publication date

2006-06-15

2002-08-28 Application filed by Schering Corp filed Critical Schering Corp

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE328879T1 publication Critical patent/ATE328879T1/de

Links

102000004274 CCR5 Receptors Human genes 0.000 title 1
108010017088 CCR5 Receptors Proteins 0.000 title 1
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Dermatology (AREA)
Virology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

AT02766142T 2001-08-29 2002-08-28 Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv ATE328879T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US31568301P	2001-08-29	2001-08-29

Publications (1)

Publication Number	Publication Date
ATE328879T1 true ATE328879T1 (de)	2006-06-15

Family

ID=23225580

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02766142T ATE328879T1 (de)	2001-08-29	2002-08-28	Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv

Country Status (23)

Country	Link
US (4)	US20040010008A1 (de)
EP (1)	EP1421075B1 (de)
JP (2)	JP4223950B2 (de)
KR (1)	KR20040029057A (de)
CN (1)	CN1304389C (de)
AR (1)	AR036366A1 (de)
AT (1)	ATE328879T1 (de)
BR (1)	BR0212108A (de)
CA (1)	CA2457861A1 (de)
CY (1)	CY1105198T1 (de)
DE (1)	DE60212146T2 (de)
DK (1)	DK1421075T3 (de)
EC (1)	ECSP044993A (de)
ES (1)	ES2264491T3 (de)
HU (1)	HUP0402019A3 (de)
IL (1)	IL160060A0 (de)
MX (1)	MXPA04001886A (de)
NO (1)	NO20041266L (de)
PL (1)	PL368827A1 (de)
PT (1)	PT1421075E (de)
RU (1)	RU2004109510A (de)
WO (1)	WO2003020716A1 (de)
ZA (1)	ZA200401594B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0108876D0 (en) *	2001-04-09	2001-05-30	Novartis Ag	Organic Compounds
ATE319703T1 (de)	2001-07-02	2006-03-15		Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen
SE0200844D0 (sv)	2002-03-19	2002-03-19	Astrazeneca Ab	Chemical compounds
SE0200843D0 (sv)	2002-03-19	2002-03-19	Astrazeneca Ab	Chemical compounds
GB0223223D0 (en) *	2002-10-07	2002-11-13	Novartis Ag	Organic compounds
WO2004035541A1 (en) *	2002-10-15	2004-04-29	Janssen Pharmaceutica, N.V.	Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
SE0300957D0 (sv)	2003-04-01	2003-04-01	Astrazeneca Ab	Chemical compounds
KR20060100409A (ko) *	2003-11-03	2006-09-20	쉐링 코포레이션	케모킨 수용체 억제제로서 유용한 비피페리디닐 유도체
KR20060123292A (ko) *	2003-11-10	2006-12-01	쉐링 악티엔게젤샤프트	Ｃｃｒ-5 길항제로서 유용한 벤질에테르 아민 화합물
EA015517B1 (ru)	2004-04-13	2011-08-30	Инсайт Корпорейшн	Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора
WO2006071958A1 (en)	2004-12-29	2006-07-06	Millennium Pharmaceuticals, Inc.	Compounds useful as chemokine receptor antagonists
WO2006071875A1 (en) *	2004-12-29	2006-07-06	Millennium Pharmaceuticals, Inc.	Compounds useful as chemokine receptor antagonists
CA2595574A1 (en) *	2005-01-20	2006-07-27	Pfizer Limited.	Chemical compounds
JP4822367B2 (ja) *	2005-02-23	2011-11-24	シェーリングコーポレイション	ケモカイン受容体のインヒビターとして有用なピペリジニルピペリジン誘導体
US20070010565A1 (en) *	2005-04-25	2007-01-11	Olaf Prien	New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
JP2009501793A (ja)	2005-07-21	2009-01-22	アストラゼネカ・アクチエボラーグ	新規ピペリジン誘導体
US8119661B2 (en) *	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
RU2010116821A (ru) *	2007-10-01	2011-11-10	Ф.Хоффманн-Ля Аг (Ch)	N-гетероциклические биарильные карбоксамиды в качестве антагонистов рецептора ccr
AU2009259496A1 (en) *	2008-06-18	2009-12-23	F. Hoffmann-La Roche Ag	Novel heteroaryl carboxamide derivatives
GB201017345D0 (en)	2010-10-14	2010-11-24	Proximagen Ltd	Receptor antagonists
EP3083610A1 (de)	2013-12-19	2016-10-26	Bayer Pharma Aktiengesellschaft	Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
CR20160276A (es)	2013-12-19	2016-10-20	Bayer Pharma AG	"piperidiniltetrahidroquinolinas sustituidas y su uso como antagonistas de los adenoreceptores alpha-2c"
KR20160098424A (ko)	2013-12-19	2016-08-18	바이엘 파마 악티엔게젤샤프트	치환된 피페리디닐-테트라히드로퀴놀린
US20160318866A1 (en)	2013-12-19	2016-11-03	Bayer Pharma Aktiengesellschaft	Substituted bipiperidinyl derivatives
AU2016242118B2 (en)	2015-04-02	2021-07-08	Proximagen, Llc	Novel therapies for cancer
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
WO2023023532A2 (en) *	2021-08-18	2023-02-23	Chemocentryx, Inc.	Aryl sulfonyl (hydroxy) piperidines as ccr6 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4588722A (en) *	1984-01-09	1986-05-13	Janssen Pharmaceutica N.V.	N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
TW531537B (en) *	1995-12-27	2003-05-11	Janssen Pharmaceutica Nv	1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
ES2182104T3 (es) *	1996-07-10	2003-03-01	Schering Corp	Piperidinas 1,4-disustituidas como antagonistas muscarinicos.
US5952349A (en) *	1996-07-10	1999-09-14	Schering Corporation	Muscarinic antagonists for treating memory loss
KR100439357B1 (ko) *	1999-05-04	2004-07-07	쉐링 코포레이션	Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체
WO2001030348A1 (en) *	1999-10-25	2001-05-03	Janssen Pharmaceutica N.V.	Use of substance p antagonists for influencing the circadian timing system
AR033517A1 (es) *	2000-04-08	2003-12-26	Astrazeneca Ab	Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0108876D0 (en) *	2001-04-09	2001-05-30	Novartis Ag	Organic Compounds

2002
- 2002-08-27 AR ARP020103217A patent/AR036366A1/es unknown
- 2002-08-28 PT PT02766142T patent/PT1421075E/pt unknown
- 2002-08-28 JP JP2003524986A patent/JP4223950B2/ja not_active Expired - Fee Related
- 2002-08-28 EP EP02766142A patent/EP1421075B1/de not_active Expired - Lifetime
- 2002-08-28 PL PL02368827A patent/PL368827A1/xx not_active Application Discontinuation
- 2002-08-28 DK DK02766142T patent/DK1421075T3/da active
- 2002-08-28 RU RU2004109510/04A patent/RU2004109510A/ru not_active Application Discontinuation
- 2002-08-28 IL IL16006002A patent/IL160060A0/xx unknown
- 2002-08-28 MX MXPA04001886A patent/MXPA04001886A/es active IP Right Grant
- 2002-08-28 ES ES02766142T patent/ES2264491T3/es not_active Expired - Lifetime
- 2002-08-28 HU HU0402019A patent/HUP0402019A3/hu unknown
- 2002-08-28 BR BR0212108-5A patent/BR0212108A/pt not_active IP Right Cessation
- 2002-08-28 CA CA002457861A patent/CA2457861A1/en not_active Abandoned
- 2002-08-28 WO PCT/US2002/027389 patent/WO2003020716A1/en not_active Ceased
- 2002-08-28 US US10/229,466 patent/US20040010008A1/en not_active Abandoned
- 2002-08-28 KR KR10-2004-7002835A patent/KR20040029057A/ko not_active Withdrawn
- 2002-08-28 CN CNB028166795A patent/CN1304389C/zh not_active Expired - Fee Related
- 2002-08-28 AT AT02766142T patent/ATE328879T1/de not_active IP Right Cessation
- 2002-08-28 DE DE60212146T patent/DE60212146T2/de not_active Expired - Lifetime
2003
- 2003-07-29 US US10/629,466 patent/US7442703B2/en not_active Expired - Fee Related
- 2003-07-29 US US10/628,933 patent/US7384948B2/en not_active Expired - Fee Related
2004
- 2004-02-25 ZA ZA200401594A patent/ZA200401594B/en unknown
- 2004-02-27 EC EC2004004993A patent/ECSP044993A/es unknown
- 2004-03-26 NO NO20041266A patent/NO20041266L/no not_active Application Discontinuation
2006
- 2006-09-06 CY CY20061101271T patent/CY1105198T1/el unknown
2008
- 2008-04-17 US US12/104,914 patent/US8034933B2/en not_active Expired - Fee Related
- 2008-05-22 JP JP2008134844A patent/JP2008222722A/ja active Pending

Also Published As

Publication number	Publication date
IL160060A0 (en)	2004-06-20
JP2005502682A (ja)	2005-01-27
HUP0402019A3 (en)	2009-07-28
ZA200401594B (en)	2004-11-24
ECSP044993A (es)	2004-04-28
KR20040029057A (ko)	2004-04-03
AR036366A1 (es)	2004-09-01
US8034933B2 (en)	2011-10-11
CA2457861A1 (en)	2003-03-13
PT1421075E (pt)	2006-10-31
ES2264491T3 (es)	2007-01-01
EP1421075B1 (de)	2006-06-07
JP4223950B2 (ja)	2009-02-12
CN1551877A (zh)	2004-12-01
US20040092745A1 (en)	2004-05-13
US7442703B2 (en)	2008-10-28
US7384948B2 (en)	2008-06-10
WO2003020716A1 (en)	2003-03-13
DE60212146T2 (de)	2007-06-06
EP1421075A1 (de)	2004-05-26
US20080214575A1 (en)	2008-09-04
MXPA04001886A (es)	2004-06-15
CY1105198T1 (el)	2010-03-03
NO20041266L (no)	2004-03-26
HUP0402019A2 (hu)	2005-02-28
BR0212108A (pt)	2004-08-24
US20040010008A1 (en)	2004-01-15
US20040092551A1 (en)	2004-05-13
HK1061563A1 (en)	2004-09-24
DK1421075T3 (da)	2006-09-18
PL368827A1 (en)	2005-04-04
CN1304389C (zh)	2007-03-14
RU2004109510A (ru)	2005-10-20
JP2008222722A (ja)	2008-09-25
DE60212146D1 (de)	2006-07-20

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1421075

Country of ref document: EP

2011-05-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60212146D1 (de)	2006-07-20	Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv
DE60021371D1 (de)	2005-08-25	Piperidinderivate verwendbar als ccr5 antagonisten
NO20034311D0 (no)	2003-09-26	CCR5-antagonister for behandling av AIDS
ATE250605T1 (de)	2003-10-15	Piperidin verbindung zur behandlung von psoriasis
BR0308452A (pt)	2006-06-06	composições farmacêuticas e métodos de preparação de composição farmacêutica
NO20050429D0 (no)	2005-01-26	Substituert kinolin-CCR5-reseptorantagonister
DE60231341D1 (de)	2009-04-09	Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
DE60318013D1 (de)	2008-01-24	N-oxid von n-phenyl-2-pyrimidinaminderivaten
DE60220661D1 (de)	2007-07-26	Transdermales pflaster zur verabreichung von fentanyl
DE60039446D1 (de)	2008-08-21	Cyclische aminverbindung als ccr5 antagonist
CH1175401H1 (de)	2007-02-15	Piperazin Derivate verwendbar als CCR5 Antagonisten
ATE382353T1 (de)	2008-01-15	Substiuierte piperidine als melanocortinrezeptor- modulatoren
ATE451921T1 (de)	2010-01-15	Phenylindole zur behandlung von hiv
ATE371451T1 (de)	2007-09-15	Duale nk1/nk3 antagonisten zur behandlung von schizophrenie
ATE334965T1 (de)	2006-08-15	Piperidinverbindungen als muscarinantagonisten
DE60239711D1 (de)	2011-05-19	Substituierte Carbostyrilderivate als 5-HT1A-Subtyp Agonisten zur Behandlung von bipolarer Störung
ATE315566T1 (de)	2006-02-15	Heteroaryl derivate als bessere liganden des nociceptinrezeptors orl-1
DE60221275D1 (de)	2007-08-30	Piperazin-derivate zur verwendung als ccr-3 rezeptor antagonisten zur behandlung von asthma
DE60313898D1 (de)	2007-06-28	Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
ATE282041T1 (de)	2004-11-15	Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
DE602004013427D1 (de)	2008-06-12	Biaryltetrahydroisochinolin-piperidine als selektive mch-rezeptor-antagonisten zur behandlung von adipositas und verwandten erkrankungen
DE60330373D1 (de)	2010-01-14	Piperidinderivate als ccr5-inhibitoren
BR0317363A (pt)	2005-11-16	Antagonista de npy-5
DE602004006424D1 (de)	2007-06-21	Piperidinderivate als ccr5-rezeptormodulatoren
SI1421075T1 (sl)	2006-10-31	Derivati piperidina, koristni kot antagonisti CCR5